Keywords
How to Cite
Abstract
Despite its aggressive behavior and translational potential, malignant eyelid melanoma in dogs remains under-researched in veterinary oncology. This study aimed to elucidate the molecular landscape of a malignant eyelid melanoma in a 4-year-old female dog of an undefined breed. Differential gene expression analysis revealed 1,437 significantly altered genes. Notably, the upregulated genes were enriched in immune-related pathways, such as chemokine signaling (CCL3, CCL4, CCL8, CCL23, CCL24, CXCL8, and CXCL10), whereas the downregulated genes were associated with cytoskeletal integrity processes and hormonal signaling. MicroRNA analysis highlighted miR-134-5p and miR-146a-5p as potential regulators of oncogenic pathways, underscoring their diagnostic and therapeutic importance. In addition, comparative analyses revealed conserved gene signatures in human basal cell carcinoma of the eyelids, emphasizing the importance of canine models in translational oncology. This comprehensive molecular characterization provides new insights into the pathogenesis of canine eyelid melanoma and identifies key biomarkers and pathways that may be relevant for future therapeutic interventions in veterinary and comparative oncology.
References
Adams, R., Moser, B., Karagiannis, S. N., & Lacy, K. E. (2021). Chemokine pathways in cutaneous melanoma: Their modulation by cancer and exploitation by the clinician. Cancers (Basel), 13(22), 5625. https://doi.org/10.3390/ cancers13225625. PMid:34830780.
Alshammari, A. H., Oshiro, T., Ungkulpasvich, U., Yamaguchi, J., Morishita, M., Khdair, S. A., Hatakeyama, H., Hirotsu, T., & di Luccio, E. (2025). Advancing veterinary oncology: Next-generation diagnostics for early cancer detection and clinical implementation. Animals (Basel), 15(3), 389. https://doi.org/10.3390/ani15030389. PMid:39943159.
Avallone, G., Rasotto, R., Chambers, J. K., Miller, A. D., Behling-Kelly, E., Monti, P., Berlato, D., Valenti, P., & Roccabianca, P. (2021). Review of histological grading systems in veterinary medicine. Veterinary Pathology, 58(5), 809-828. https://doi.org/10.1177/0300985821999831. PMid:33769136.
Barbai, T., Fejos, Z., Puskas, L. G., Timar, J., & Raso, E. (2015). The importance of microenvironment: The role of CCL8 in metastasis formation of melanoma. Oncotarget, 6(30), 29111-29128. https://doi.org/10.18632/ oncotarget.5059. PMid:26320180.
Barrio-Alonso, C., Nieto-Valle, A., Garcia-Martinez, E., Gutierrez-Seijo, A., Parra-Blanco, V., Marquez-Rodas, I., Avilés Izquierdo, J. A., Sánchez-Mateos, P., & Samaniego, R. (2024). Chemokine profiling of melanoma-macrophage crosstalk identifies CCL8 and CCL15 as prognostic factors in cutaneous melanoma. The Journal of Pathology, 262(4), 495-504. https://doi.org/10.1002/path.6252. PMid:38287901.
Brachelente, C., Cappelli, K., Capomaccio, S., Porcellato, I., Silvestri, S., Bongiovanni, L., De Maria, R., Verini Supplizi, A., Mechelli, L., & Sforna, M. (2017). Transcriptome analysis of canine cutaneous melanoma and melanocytoma reveals a modulation of genes regulating extracellular matrix metabolism and cell cycle. Scientific Reports, 7(1), 6386. https://doi.org/10.1038/s41598-017-06281-1. PMid:28743863.
Cai, G., Zou, R., Yang, H., Xie, J., Chen, X., Zheng, C., Luo, S., Wei, N., Liu, S., & Chen, R. (2022). Circ_0084043-miR 134-5p axis regulates PCDH9 to suppress melanoma. Frontiers in Oncology, 12, 891476. https://doi.org/10.3389/fonc.2022.891476. PMid:36387162.
Camargo, L. P., Conceição, L. G., & Costa, P. R. S. (2008). Neoplasias melanocíticas cutâneas em cães: Estudo retrospectivo de 68 casos (1996-2004). Brazilian Journal of Veterinary Research and Animal Science, 45(2), 138-152. https://doi.org/10.11606/issn.1678-4456.bjvras.2008.26711.
Cassali, G. D., Silva, P., Rêma, A., Gärtner, F., Gobbi, H., Tafuri, W. L., & Schmitt, F. C. (2001). A new methodology for the improvement of diagnostic immunohistochemistry in canine veterinary pathology: Automated system using human monoclonal and polyclonal antibodies. Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 53(3), 326-331. https://doi.org/10.1590/S0102-09352001000300010.
Castillo, L., Rohatgi, A., Ayers, C. R., Owens, A. W., Das, S. R., Khera, A., McGuire, D. K., & de Lemos, J. A. (2010). Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: Results from the dallas heart study. Journal of Interferon & Cytokine Research : The Official Journal of the International Society for Interferon and Cytokine Research, 30(5), 339-347. https://doi.org/10.1089/jir.2009.0045. PMid:20187767.
Catchpole, B., Gould, S. M., Kellett-Gregory, L. M., & Dobson, J. M. (2002). Immunosuppressive cytokines in the regional lymph node of a dog suffering from oral malignant melanoma. The Journal of Small Animal Practice, 43(10), 464-467. https://doi.org/10.1111/j.1748-5827.2002.tb00015.x. PMid:12400646
Chen, Y., & Wang, X. (2020). miRDB: An online database for prediction of functional microRNA targets. Nucleic Acids Research, 48(D1), D127-D131. https://doi.org/10.1093/nar/gkz757. PMid:31504780.
Chen, Z., Li, X. Y., Guo, P., & Wang, D. L. (2021). MYBPC2 and MYL1 as significant gene markers for rhabdomyosarcoma. Technology in Cancer Research & Treatment, 20, 1533033820979669. https://doi.org/10.1177/1533033820979669. PMid:33499774.
Dai, Y., Hu, R., Liu, A., Cho, K. S., Manuel, A. M., Li, X., Dong, X., Jia, P., & Zhao, Z. (2022). WebCSEA: Web-based cell type-specific enrichment analysis of genes. Nucleic Acids Research, 50(W1), W782-W790. https://doi.org/10.1093/nar/gkac392. PMid:35610053.
Dai, Y., Hu, R., Manuel, A. M., Liu, A., Jia, P., & Zhao, Z. (2021). CSEA-DB: An omnibus for human complex trait and cell type associations. Nucleic Acids Research, 49(D1), D862-D870. https://doi.org/10.1093/nar/gkaa1064. PMid:33211888.
Diters, R. W., Dubielzig, R. R., Aguirre, G. D., & Acland, G. M. (1983). Primary ocular melanoma in dogs. Veterinary Pathology, 20(4), 379-395. https://doi.org/10.1177/030098588302000401. PMid:6623842.
Douguet, L., Bod, L., Lengagne, R., Labarthe, L., Kato, M., Avril, M. F., & Prevost-Blondel, A. (2016). Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of gammadelta17 T cells in melanoma. OncoImmunology, 5(8), e1208878. https://doi.org/10.1080/2162402X.2016.1208878. PMid:27622078.
Dow, S. W., Elmslie, R. E., Willson, A. P., Roche, L., Gorman, C., & Potter, T. A. (1998). In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. The Journal of Clinical Investigation, 101(11), 2406-2414. https://doi.org/10.1172/JCI510. PMid:9616212.
Dweep, H., Gretz, N., & Sticht, C. (2014). miRWalk database for miRNA-target interactions. Methods in Molecular Biology, 1182, 289-305. https://doi.org/10.1007/978-1-4939-1062-5_25. PMid:25055920.
Ferreira, W. A. S., & Oliveira, E. H. C. (2022). Expression of GOT2 is epigenetically regulated by DNA methylation and correlates with immune infiltrates in clear-cell renal cell carcinoma. Current Issues in Molecular Biology, 44(6), 2472-2489. https://doi.org/10.3390/cimb44060169. PMid:35735610.
Ferreira, W. A. S., Amorim, C. K. N., Burbano, R. R., Villacis, R. A. R., Marchi, F. A., Medina, T. S., Lima, M. M. C., & Oliveira, E. H. C. (2021). Genomic and transcriptomic characterization of the human glioblastoma cell line AHOL1. Brazilian Journal of Medical and Biological Research = Revista Brasileira de Pesquisas Médicas e Biológicas, 54(3), e9571. https://doi.org/10.1590/1414-431x20209571. PMid:33470396.
Ferreira, W. A. S., Vitiello, G. A. F., da Silva Medina, T., & de Oliveira, E. H. C. (2022). Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas. Scientific Reports, 12(1), 6442. https://doi.org/10.1038/s41598-022-10114-1. PMid:35440701.
Finn, M., Krohne, S., & Stiles, J. (2008). Ocular melanocytic neoplasia. Compendium: Continuing Education for Veterinarians. 30(1), 19-25; quiz 26. PMid:18278744.
Forloni, M., Dogra, S. K., Dong, Y., Conte Junior, D., Ou, J., Zhu, L. J., Deng, A., Mahalingam, M., Green, M. R., & Wajapeyee, N. (2014). miR-146a promotes the initiation and progression of melanoma by activating Notch signaling. eLife, 3, e01460. https://doi.org/10.7554/eLife.01460. PMid:24550252.
Galon, J., & Bruni, D. (2019). Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nature Reviews. Drug Discovery, 18(3), 197-218. https://doi.org/10.1038/s41573-018-0007-y. PMid:30610226.
Ge, S. X., Jung, D., & Yao, R. (2020). ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics (Oxford, England), 36(8), 2628-2629. https://doi.org/10.1093/bioinformatics/btz931. PMid:31882993.
Gillard, M., Cadieu, E., De Brito, C., Abadie, J., Vergier, B., Devauchelle, P., Degorce, F., Dréano, S., Primot, A., Dorso, L., Lagadic, M., Galibert, F., Hédan, B., Galibert, M. D., & André, C. (2014). Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas. Pigment Cell & Melanoma Research, 27(1), 90-102. https://doi.org/10.1111/pcmr.12170. PMid:24112648.
Giorgi, V., Gori, A., Grazzini, M., Rossari, S., Scarfi, F., Corciova, S., Verdelli, A., Lotti, T., & Massi, D. (2011). Estrogens, estrogen receptors and melanoma. Expert Review of Anticancer Therapy, 11(5), 739-747. https://doi.org/10.1586/ era.11.42. PMid:21554049.
Giuliano, E. A., Chappell, R., Fischer, B., & Dubielzig, R. R. (1999). A matched observational study of canine survival with primary intraocular melanocytic neoplasia. Veterinary Ophthalmology, 2(3), 185-190. https://doi.org/10.1046/j.1463-5224.1999.00080.x. PMid:11397263.
Han, K. Y., Kim, C. W., Lee, T. H., Son, Y., & Kim, J. (2009). CCL23 up-regulates expression of KDR/Flk-1 and potentiates VEGF-induced proliferation and migration of human endothelial cells. Biochemical and Biophysical Research Communications, 382(1), 124-128. https://doi.org/10.1016/j.bbrc.2009.02.149. PMid:19265684.
Han, M. G., & Kim, J. Y. (2022). Application of local anaesthesia and cryosurgery for eyelid masses in dogs. Veterinary Medicine and Science, 8(2), 476-482. https://doi.org/10.1002/vms3.688. PMid:34919349.
Harlin, H., Meng, Y., Peterson, A. C., Zha, Y., Tretiakova, M., Slingluff, C., McKee, M., & Gajewski, T. F. (2009). Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Research, 69(7), 3077-3085. https://doi.org/10.1158/0008-5472.CAN-08-2281. PMid:19293190.
Hernandez, B., Adissu, H. A., Wei, B. R., Michael, H. T., Merlino, G., & Simpson, R. M. (2018). Naturally occurring canine melanoma as a predictive comparative oncology model for human mucosal and other triple wild type melanomas. International Journal of Molecular Sciences, 19(2), 394. https://doi.org/10.3390/ijms19020394. PMid:29385676.
Huntington, J. T., Shields, J. M., Der, C. J., Wyatt, C. A., Benbow, U., Slingluff Junior, C. L., & Brinckerhoff, C. E. (2004). Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: Role of BRAF mutation and fibroblast growth factor signaling. The Journal of Biological Chemistry, 279(32), 33168-33176. https://doi.org/10.1074/jbc.M405102200. PMid:15184373.
Iida, J., & McCarthy, J. B. (2007). Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta. Melanoma Research, 17(4), 205-213. https://doi.org/10.1097/ CMR.0b013e3282a660ad. PMid:17625450.
Kamat, K., Krishnan, V., & Dorigo, O. (2022). Macrophage-derived CCL23 upregulates expression of T-cell exhaustion markers in ovarian cancer. British Journal of Cancer, 127(6), 1026-1033. https://doi.org/10.1038/ s41416-022-01887-3. PMid:35750747.
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012). KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Research, 40(Database issue), D109-D114. https://doi.org/10.1093/ nar/gkr988. PMid:22080510.
Karagkouni, D., Paraskevopoulou, M. D., Chatzopoulos, S., Vlachos, I. S., Tastsoglou, S., Kanellos, I., Papadimitriou, D., Kavakiotis, I., Maniou, S., Skoufos, G., Vergoulis, T., Dalamagas, T., & Hatzigeorgiou, A. G. (2018). DIANA TarBase v8: A decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Research, 46(D1), D239-D245. https://doi.org/10.1093/nar/gkx1141. PMid:29156006.
Kure, S., Yoshie, O., & Aso, H. (1987). Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan. Japanese Journal of Cancer Research : Gann, 78(11), 1238-1245. PMid:2961717.
Leonardi, L., Scotlandi, K., Pettinari, I., Benassi, M. S., Porcellato, I., & Pazzaglia, L. (2021). MiRNAs in canine and human osteosarcoma: A highlight review on comparative biomolecular aspects. Cells, 10(2), 428. https://doi.org/10.3390/cells10020428. PMid:33670554.
Li, C., Guan, R., Li, W., Wei, D., Cao, S., Chang, F., Wei, Q., Wei, R., Chen, L., Xu, C., Wu, K., & Lei, D. (2023). Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC. BMC Cancer, 23(1), 840. https://doi.org/10.1186/ s12885-023-11349-5. PMid:37679666.
Li, R., Qu, H., Wang, S., Chater, J. M., Wang, X., Cui, Y., Yu, L., Zhou, R., Jia, Q., Traband, R., Wang, M., Xie, W., Yuan, D., Zhu, J., Zhong, W. D., & Jia, Z. (2022). CancerMIRNome: An interactive analysis and visualization database for miRNome profiles of human cancer. Nucleic Acids Research, 50(D1), D1139-D1146. https://doi.org/10.1093/nar/gkab784. PMid:34500460.
Luo, W., Pant, G., Bhavnasi, Y. K., Blanchard Junior, S. G., & Brouwer, C. (2017). Pathview Web: User friendly pathway visualization and data integration. Nucleic Acids Research, 45(W1), W501-W508. https://doi.org/10.1093/nar/ gkx372. PMid:28482075.
Luz, J. C. S., Voges, A. C., & D’Agostino, L. G. (2023). Adjuvant electrochemotherapy of malignant ocular melanoma in a dog. Veterinary Research Forum: An International Quarterly Journal, 14(10), 575-578. PMid:37901350.
Marzagalli, M., Montagnani Marelli, M., Casati, L., Fontana, F., Moretti, R. M., & Limonta, P. (2016). Estrogen receptor beta in melanoma: From molecular insights to potential clinical utility. Frontiers in Endocrinology, 7, 140. https://doi.org/10.3389/fendo.2016.00140. PMid:27833586.
Meng, J., Wang, L., Hou, J., Yang, X., Lin, K., Nan, H., Li, M., Wu, X., & Chen, X. (2021). CCL23 suppresses liver cancer progression through the CCR1/AKT/ESR1 feedback loop. Cancer Science, 112(8), 3099-3110. https://doi.org/10.1111/ cas.14995. PMid:34050704.
Menyhart, O., Kothalawala, W. J., & Győrffy, B. (2025). A gene set enrichment analysis for cancer hallmarks. Journal of Pharmaceutical Analysis, 15(5), 101065. https://doi.org/10.1016/j.jpha.2024.101065. PMid:40496069.
Natale, C. A., Li, J., Zhang, J., Dahal, A., Dentchev, T., Stanger, B. Z., & Ridky, T. W. (2018). Activation of G protein coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade. eLife, 7, e31770. https://doi.org/10.7554/eLife.31770. PMid:29336307.
Payne, A. S., & Cornelius, L. A. (2002). The role of chemokines in melanoma tumor growth and metastasis. The Journal of Investigative Dermatology, 118(6), 915-922. https://doi.org/10.1046/j.1523-1747.2002.01725.x. PMid:12060384.
Poorman, K., Borst, L., Moroff, S., Roy, S., Labelle, P., Motsinger-Reif, A., & Breen, M. (2015). Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization. Chromosome Research : An International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology, 23(2), 171-186. https://doi.org/10.1007/s10577-014-9444-6. PMid:25511566.
Poposki, J. A., Uzzaman, A., Nagarkar, D. R., Chustz, R. T., Peters, A. T., Suh, L. A., Carter, R., Norton, J., Harris, K. E., Grammer, L. C., Tan, B. K., Chandra, R. K., Conley, D. B., Kern, R. C., Schleimer, R. P., & Kato, A. (2011). Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps. The Journal of Allergy and Clinical Immunology, 128(1), 73-81.e74. https://doi.org/10.1016/j.jaci.2011.03.017. PMid:21497884.
Prouteau, A., & Andre, C. (2019). Canine melanomas as models for human melanomas: clinical, histological, and genetic comparison. Genes, 10(7), 501. https://doi.org/10.3390/genes10070501. PMid:31262050.
Rahman, M. M., Lai, Y. C., Husna, A. A., Chen, H. W., Tanaka, Y., Kawaguchi, H., Hatai, H., Miyoshi, N., Nakagawa, T., Fukushima, R., & Miura, N. (2020). Transcriptome analysis of dog oral melanoma and its oncogenic analogy with human melanoma. Oncology Reports, 43(1), 16-30. https://doi.org/10.3892/or.2019.7391. PMid:31661138.
Raimo, M., Orso, F., Grassi, E., Cimino, D., Penna, E., De Pitta, C., Stadler, M. B., Primo, L., Calautti, E., Quaglino, P., Provero, P., & Taverna, D. (2016). miR-146a exerts differential effects on melanoma growth and metastatization. Molecular Cancer Research, 14(6), 548-562. https://doi.org/10.1158/1541-7786.MCR-15-0425-T. PMid:27311960.
Ribeiro, M. P. C., Santos, A. E., & Custodio, J. B. A. (2015). Rethinking tamoxifen in the management of melanoma: New answers for an old question. European Journal of Pharmacology, 764, 372-378. https://doi.org/10.1016/j.ejphar.2015.07.023. PMid:26165763.
Riis, R. C., Vitali, C. M., & Simons, K. B. (2002). Eyelid tumors. In R. L. Peiffer Junior & K. B. Simons (Eds.), Ocular tumors in animals and humans (pp. 25-86). Wiley. https://doi.org/10.1002/9780470376904.ch2.
Roberts, S. M., Severin, G. A., & Lavach, J. D. (1986). Prevalence and treatment of palpebral neoplasms in the dog: 200 cases (1975-1983). Journal of the American Veterinary Medical Association, 189(10), 1355-1359. https://doi.org/10.2460/javma.1986.189.10.1355. PMid:3793587.
Ryan, A. M., & Diters, R. W. (1984). Clinical and pathologic features of canine ocular melanomas. Journal of the American Veterinary Medical Association, 184(1), 60-67. https://doi.org/10.2460/javma.1984.184.01.60. PMid:6698840.
Seiz, V., Sames, K., & Schmiegelow, P. (1990). [Histotopochemical quantification of glycosaminoglycans in melanomas and the surrounding epidermis]. Dermatologische Monatsschrift, 176(12), 745-755. https://www.ncbi.nlm.nih.gov/ pubmed/2094611.
Serra, M., Pastor, J., Domenzain, C., & Bassols, A. (2002). Effect of transforming growth factor-beta1, insulin-like growth factor-I, and hepatocyte growth factor on proteoglycan production and regulation in canine melanoma cell lines. American Journal of Veterinary Research, 63(8), 1151-1158. https://doi.org/10.2460/ajvr.2002.63.1151. PMid:12171170.
Sherman, B. T., Hao, M., Qiu, J., Jiao, X., Baseler, M. W., Lane, H. C., Imamichi, T., & Chang, W. (2022). DAVID: A web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Research, 50(W1), W216-W221. https://doi.org/10.1093/nar/gkac194. PMid:35325185.
Simpson, R. M., Bastian, B. C., Michael, H. T., Webster, J. D., Prasad, M. L., Conway, C. M., Prieto, V. M., Gary, J. M., Goldschmidt, M. H., Esplin, D. G., Smedley, R. C., Piris, A., Meuten, D. J., Kiupel, M., Lee, C. C., Ward, J. M., Dwyer, J. E., Davis, B. J., Anver, M. R., Molinolo, A. A., Hoover, S. B., Rodriguez-Canales, J., & Hewitt, S. M. (2014). Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Pigment Cell & Melanoma Research, 27(1), 37-47. https://doi.org/10.1111/pcmr.12185. PMid:24128326.
Smetsers, T. F., van de Westerlo, E. M., ten Dam, G. B., Clarijs, R., Versteeg, E. M., van Geloof, W. L., Veerkamp, J. H., van Muijen, G. N., & van Kuppevelt, T. H. (2003). Localization and characterization of melanoma-associated glycosaminoglycans: Differential expression of chondroitin and heparan sulfate epitopes in melanoma. Cancer Research, 63(11), 2965-2970. PMid:12782604.
Stinson, J. A., Barbosa, M. M. P., Sheen, A., Momin, N., Fink, E., Hampel, J., Selting, K., Kamerer, R., Bailey, K. L., Wittrup, K. D., & Fan, T. M. (2024). Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogs. bioRxiv. 1-33. https://doi.org/10.1101/2024.02.12.579965.
Takeuchi, H., Konnai, S., Maekawa, N., Takagi, S., Ohta, H., Sasaki, N., Kim, S., Okagawa, T., Suzuki, Y., Murata, S., & Ohashi, K. (2021). Canine transforming growth Factor-beta Receptor 2-Ig: A potential candidate biologic for melanoma treatment that reverses transforming growth Factor-beta1 immunosuppression. Frontiers in Veterinary Science, 8, 656715. https://doi.org/10.3389/fvets.2021.656715. PMid:34195245.
Tastsoglou, S., Skoufos, G., Miliotis, M., Karagkouni, D., Koutsoukos, I., Karavangeli, A., Kardaras, F. S., & Hatzigeorgiou, A. G. (2023). DIANA-miRPath v4.0: Expanding target-based miRNA functional analysis in cell-type and tissue contexts. Nucleic Acids Research, 51(W1), W154-W159. https://doi.org/10.1093/nar/gkad431. PMid:37260078.
Tuntivanich, N., Tuntivanich, P., Wongaumnuaykul, S., & Rungsipipat, A. (2004). The prevalence and treatment of eyelid neoplasms in dogs: 69 cases (2000-2003). Wetchasan Sattawaphaet, 34(4), 121-128. https://doi.org/10.56808/2985-1130.1978.
Varvil, M. S., & Dos Santos, A. P. (2023). A review on microRNA detection and expression studies in dogs. Frontiers in Veterinary Science, 10, 1261085. https://doi.org/10.3389/fvets.2023.1261085. PMid:37869503.
Wang, A. L., & Kern, T. (2015). Melanocytic ophthalmic neoplasms of the domestic veterinary species: A review. Topics in Companion Animal Medicine, 30(4), 148-157. https://doi.org/10.1053/j.tcam.2015.06.001. PMid:27154598.
Wang, S. L., Dawson, C., Wei, L. N., & Lin, C. T. (2019). The investigation of histopathology and locations of excised eyelid masses in dogs. Veterinary Record Open, 6(1), e000344. https://doi.org/10.1136/vetreco-2019-000344. PMid:31897299.
Wong, K., van der Weyden, L., Schott, C. R., Foote, A., Constantino-Casas, F., Smith, S., Dobson, J. M., Murchison, E. P., Wu, H., Yeh, I., Fullen, D. R., Joseph, N., Bastian, B. C., Patel, R. M., Martincorena, I., Robles-Espinoza, C. D., Iyer, V., Kuijjer, M. L., Arends, M. J., Brenn, T., Harms, P. W., Wood, G. A., & Adams, D. J. (2019). Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma. Nature Communications, 10(1), 353. https://doi.org/10.1038/s41467-018-08081-1. PMid:30664638.
Yunoki, T., Tabuchi, Y., Hirano, T., Miwa, S., Imura, J., & Hayashi, A. (2018). Gene networks in basal cell carcinoma of the eyelid, analyzed using gene expression profiling. Oncology Letters, 16(5), 6729-6734. https://doi.org/10.3892/ ol.2018.9484. PMid:30405815.
Zamarian, V., Catozzi, C., Ressel, L., Finotello, R., Ceciliani, F., Vilafranca, M., Altimira, J., & Lecchi, C. (2019). MicroRNA expression in formalin-fixed, paraffin-embedded samples of canine cutaneous and oral melanoma by RT-qPCR. Veterinary Pathology, 56(6), 848-855. https://doi.org/10.1177/0300985819868646. PMid:31526125.
Zhang, L., Huang, P., Li, Q., Wang, D., & Xu, C. X. (2019). miR-134-5p promotes stage i lung adenocarcinoma metastasis and chemoresistance by targeting DAB2. Molecular Therapy. Nucleic Acids, 18, 627-637. https://doi.org/10.1016/j.omtn.2019.09.025. PMid:31689617.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Wallax Augusto Silva Ferreira, Antonio Gomes Costa Neto de Sousa, Thamirys Aline Silva Faro, Edivaldo Herculano Correa de Oliveira